Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov.

Published by须 慎 Modified over 7 years ago

Similar presentations

Presentation on theme: "Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov."— Presentation transcript:

1 Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registry  Sabrina Bernardez-Pereira, MD, MS, Renato D. Lopes, MD, PhD, Maria Julia Machline Carrion, MD, MS, Eliana Vieira Santucci, MS, Rafael Marques Soares, MS, Matheus de Oliveira Abreu, MS, Ligia Nasi Laranjeira, MS, Dimas T. Ikeoka, MD, PhD, Ana Denise Zazula, MD, Frederico Rafael Moreira, MS, Alexandre Biasi Cavalcanti, MD, PhD, Evandro Tinoco Mesquita, MD, PhD, Eric D. Peterson, MD, MPH, Robert M. Califf, MD, Otavio Berwanger, MD, PhD  American Heart Journal  Volume 168, Issue 2, Pages e1 (August 2014) DOI: /j.ahj Copyright © 2014 Mosby, Inc. Terms and Conditions

2 Figure 1 Study design—flowchart of systematic analysis of cardiovascular interventional trials registered in ClinicalTrials.gov. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2014 Mosby, Inc. Terms and Conditions

3 Figure 2 Multivariable logistic regression analysis assessing predictors of early termination of cardiovascular clinical trials due to low recruitment. American Heart Journal  , e1DOI: ( /j.ahj ) Copyright © 2014 Mosby, Inc. Terms and Conditions

Download ppt "Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov."

Similar presentations

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,
Joann R. Petrini, PhD, MPH, Todd Dias, MS, Marie C

Joann R. Petrini, PhD, MPH, Todd Dias, MS, Marie C
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial  Bruce.

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial  Bruce.
Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.
Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading.

Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading.
Downstream coronary effects of drug-eluting stents

Downstream coronary effects of drug-eluting stents
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.
Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial  Erik Kjøller, MD, DMSc, Jørgen Hilden,
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.

The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation  Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.
The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics  Cheryl Bushnell,

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics  Cheryl Bushnell,
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.
CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy.

CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy.
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.

Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population  Richard K. Cheng, MD, MS,

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population  Richard K. Cheng, MD, MS,

Similar presentations

Ads by Google